EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors.
about
EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
EGFR Mutation Status in Lung A ...... FR Tyrosine Kinase Inhibitors.
@en
EGFR Mutation Status in Lung A ...... FR Tyrosine Kinase Inhibitors.
@nl
type
label
EGFR Mutation Status in Lung A ...... FR Tyrosine Kinase Inhibitors.
@en
EGFR Mutation Status in Lung A ...... FR Tyrosine Kinase Inhibitors.
@nl
prefLabel
EGFR Mutation Status in Lung A ...... FR Tyrosine Kinase Inhibitors.
@en
EGFR Mutation Status in Lung A ...... FR Tyrosine Kinase Inhibitors.
@nl
P2093
P2860
P356
P1476
EGFR Mutation Status in Lung A ...... FR Tyrosine Kinase Inhibitors.
@en
P2093
Chang Gok Woo
Hye Sook Han
Jihyun Kwon
Jiyoul Yang
Ki Hyeong Lee
Ok-Jun Lee
Seung-Myoung Son
Yaewon Yang
Yusook Jeong
P2860
P356
10.4143/CRT.2017.378
P577
2017-09-19T00:00:00Z